Delivery Order SPE2D021DA002-SPE2D325F284K
- Not listed
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $2,966.25 to DMS Pharmaceutical Group Inc. for M-M-R II vaccine vials. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order is scheduled for completion by September 12, 2025, and represents a routine procurement of immunization products for military and federal healthcare facilities....
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order for $8,495.10 to supply 4562724754 M-M-R II vaccine vials to the Defense Logistics Agency. The delivery order was issued against DMS Pharmaceutical Group's existing indefinite delivery contract with the Defense Logistics Agency to provide pharmaceuticals and medical supplies with a potential value of up to $5 million through December 2025. No set-aside designation was used for this award. DMS Pharmaceutical Group...
- This federal contract award from the Defense Logistics Agency (DLA) is a firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $10,203.30 contract is for the delivery of M-M-R II vaccine vials, with a completion date of August 7, 2024. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,133.72 firm fixed-price delivery order is for the supply of M-M-R II vaccine vials, with a performance period through August 14, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Park Ridge, Illinois. The $11,337 contract is for the delivery of M-M-R II vaccine vials, with a completion date of March 5, 2024. The contract is issued under DMS Pharmaceutical Group's indefinite delivery contract 4600082013 with the DLA, valued at up to $4,999,999 through 2025. This single-award vehicle allows...
- The Defense Logistics Agency Troop Support Medical awarded a $601.60 firm fixed price delivery order to DMS Pharmaceutical Group Inc. to supply 4561634925 M-M-R II vaccine vials. As the Defense Logistics Agency is responsible for worldwide logistics support of the Department of Defense, this delivery order was likely placed to replenish vaccine inventory for DOD personnel. DMS Pharmaceutical Group will deliver the M-M-R II vaccines to a location in Park Ridge, Illinois by July 31, 2023 to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $22,674.00 firm fixed-price delivery order is for the supply of M-M-R II vaccine vials, with a period of performance running through August 6, 2024. This award is part of a larger indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, valued at up...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is valued at $4,152.75 and covers the delivery of M-M-R II vaccine vials to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing a comprehensive range of...
- This federal contract award is a delivery order worth $2,373.04 issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of M-M-R II vaccine vials to support the medical supply needs of military health facilities. The contract is a firm fixed-price delivery order with a completion date of February 28, 2025. DMS Pharmaceutical Group Inc. also holds a...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order for $1,592.67 under an indefinite delivery contract with the Defense Logistics Agency to supply measles, mumps and rubella vaccines. The delivery order was awarded on November 24, 2021 with a completion date of December 9, 2021. No set-aside designation was used for this award. DMS Pharmaceutical Group will supply the vaccines to Defense Logistics Agency Troop Support Medical facilities located in Park Ridge,...
- SPE2D021DA002Indefinite Delivery Contract
- SPE2D021DA002-SPE2D325F284KDelivery Order
The U.S. Defense Logistics Agency, through its Medical Supply Chain division, awarded a delivery order to DMS Pharmaceutical Group Inc. for the supply of M-M-R II vaccine vials. This $19.8K firm fixed-price delivery order was executed on August 4, 2025, with an ultimate completion date of August 7, 2025, and will be performed in Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, was selected without a set-aside designation based on its established capabilities in the federal pharmaceutical supply chain. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at $500M and valid through November 2026. As a key supplier of pharmaceutical products to military health facilities nationwide, the company fulfills delivery orders for branded and generic prescription medications, biologics, vaccines, and medical consumables supporting the Department of Defense healthcare system. The M-M-R II vaccine vials represent one of the specialized pharmaceutical products within the contractor's extensive portfolio of medical supplies distributed to federal agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.8k | 8/4/25 |